Lexaria Bioscience

Lexaria Bioscience Corp. has developed a disruptive and cost-effective DehydraTECH™ technology, which promotes healthier methods of administration, reduces total dosage, and enhances the effectiveness of ingestible drugs and other beneficial molecules. Lexaria's DehydraTECH™ delivery technology is protected by a series of patents granted or pending worldwide and has been proven effective in significantly aiding the rapid and substantial absorption of a range of lipophilic substances in multiple international studies. By markedly improving the performance and experience of oral administration, Lexaria’s DehydraTECH™ offers a viable and often healthier alternative to other widely-used delivery methods for bioactive substances.